Siemens Fonds Invest’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.93M Buy
11,930
+252
+2% +$112K 0.29% 74
2026
Q1
$5.21M Buy
11,678
+466
+4% +$217K 0.3% 77
2025
Q4
$5.09M Buy
11,212
+470
+4% +$203K 0.27% 86
2025
Q3
$4.21M Sell
10,742
-173
-2% -$72.3K 0.23% 110
2025
Q2
$4.86M Buy
10,915
+307
+3% +$141K 0.29% 86
2025
Q1
$5.14M Sell
10,608
-311
-3% -$145K 0.35% 65
2024
Q4
$4.36M Sell
10,919
-1,648
-13% -$764K 0.29% 84
2024
Q3
$4.78M Sell
12,567
-712
-5% -$342K 0.38% 59
2024
Q2
$6.22M Buy
13,279
+109
+0.8% +$47.3K 0.47% 45
2024
Q1
$5.51M Sell
13,170
-441
-3% -$186K 0.42% 56
2023
Q4
$5.54M Buy
13,611
+3,111
+30% +$1.15M 0.45% 51
2023
Q3
$3.65M Buy
10,500
+2,458
+31% +$860K 0.37% 70
2023
Q2
$2.82M Hold
8,042
0.27% 98
2023
Q1
$2.53M Buy
8,042
+96
+1% +$28.8K 0.27% 108
2022
Q4
$2.29M Buy
7,946
+6
+0.1% +$1.83K 0.23% 113
2022
Q3
$2.3M Sell
7,940
-245
-3% -$70.5K 0.26% 110
2022
Q2
$2.31M Sell
8,185
-21
-0.3% -$5.62K 0.24% 115
2022
Q1
$2.14M Hold
8,206
0.17% 133
2021
Q4
$1.82M Buy
8,206
+381
+5% +$74.1K 0.12% 158
2021
Q3
$1.42M Buy
+7,825
New +$1.53M 0.09% 168

Other funds holding VRTX

Siemens Fonds Invest's VRTX Position: Q2 2026 in Review

Siemens Fonds Invest increased its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q2 2026, buying an estimated $112K and bringing the position to 11,930 shares worth $5.93M. The position accounts for 0.29% of the portfolio, ranked #74.

Siemens Fonds Invest first reported a position in VRTX in Q3 2021 and has held it in 20 quarters since. The position peaked at $6.22M in Q2 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Siemens Fonds Invest held 11,930 shares of Vertex Pharmaceuticals worth $5.93M as of Q2 2026.
  • Siemens Fonds Invest bought 252 Vertex Pharmaceuticals shares in Q2 2026, an estimated $112K.
  • Vertex Pharmaceuticals made up 0.29% of Siemens Fonds Invest's portfolio in Q2 2026, its #74 holding.
  • Siemens Fonds Invest first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • Siemens Fonds Invest's Vertex Pharmaceuticals position peaked at $6.22M in Q2 2024.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Siemens Fonds Invest's 13F filing for Q2 2026, filed 14 Aug 2026.